Spinal stimulation during walking for spasticity in cerebral palsy
Tests spinal stimulation while walking on spasticity and gait in people with cerebral palsy.
Key facts
- Who runs it
- University of Washington
- Where
- Seattle, United StatesSee the site
- Trial code
- Registry title
- Short-term Spinal Stimulation Effects in Cerebral Palsy
- Status
- Recruiting
- People taking part
- 20 people, planned
- Started
- 13 Aug 2026
- Expected to end
- 1 Dec 2028
- Type of study
- Interventional, 2 groups
- Treatments tested
- Spinal Stimulation
- Treadmill Walking
- Record updated
- 17 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with spastic cerebral palsy who can walk. It tests short-term effects of skin-surface spinal stimulation on muscle stiffness and walking.
- Age
- 4 to 65 years
- Sex
- All sexes
- Disease stage
- Spastic cerebral palsy, or a high likelihood of a CP diagnosis, with stiff leg muscles. GMFCS Level I-III (a scale of movement ability). Able to walk for at least 10 minutes, with or without support. Able to understand and follow simple directions. Stable medical condition, as reported by the caregiver or parent.
- Earlier treatment
- No leg surgery in the prior 12 months. No botulinum toxin injections in the prior 3 months. No selective dorsal rhizotomy (SDR) ever. No stem cell injections into the spinal cord.
Main reasons for not taking part
- Leg injury in the prior 12 months, or seizures that are not controlled
- Implanted stimulator or drug device, such as a pacemaker, cochlear implant or baclofen pump
- Needing a breathing machine, or serious heart or bone and muscle disease that would prevent full participation
- Established osteoporosis treated with medication, or rheumatic diseases such as rheumatoid arthritis or lupus
- Active cancer
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Individuals who:
- have a diagnosis of spastic cerebral palsy or high likelihood of CP diagnosis
- are 4-65 years of age
- have spasticity in lower-extremity muscles
- are at a functional Gross Motor Function Classification System (GMFCS) Level I-III
- can walk for at least 10 minutes with/without support
- can understand and follow simple directions
- have a stable medical condition, as reported by the caregiver/parent
Who cannot take part
- who have had lower-extremity surgery or injury in the prior 12 months
- have had botulinum toxin injections in the prior 3 months
- have implanted stimulator (e.g. epidural stimulator, vagus nerve stimulator, pacemaker, cochlear implant, etc) or drug delivery device (e.g. baclofen pump)
- have established osteoporosis and taking medication for osteoporosis treatment
- have received stem cell injections into the spinal cord
- have uncontrolled seizures
- have significant cardiovascular or musculoskeletal disease that would prevent full participation
- have rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, etc.)
- have active cancer
- Individuals who:
- have had selective dorsal rhizotomy (SDR) in the past
- are dependent on ventilation support
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 4 and 65 years old?
Where in United States
- University of WashingtonSeattle, United StatesContact: Katie Landwehr, MSTaking people
About the trial
What the trial wants to find out
This research study will examine the acute effects of non-invasive spinal stimulation on spasticity and walking in individuals with cerebral palsy. The hypothesis is that walking with spinal stimulation will lead to greater reductions in spasticity than walking without spinal stimulation. Additionally, it is hypothesized that the average step length and Gait Deviation Index will be higher while walking with spinal stimulation compared to walking without spinal stimulation.
The 2 groups in the trial
- Spinal Stimulation First (AB Arm)Treatment being tested
Participants randomized into this arm will complete two visits. The first visit will use spinal stimulation while walking on a treadmill, and the second visit will be treadmill walking without stimulation.
Treatment: Spinal Stimulation and Treadmill Walking
- No Spinal Stimulation First (BA Arm)Treatment being tested
Participants randomized into this arm will complete two visits. The first visit will involve walking on a treadmill without stimulation, while the second visit will be treadmill walking with stimulation.
Treatment: Spinal Stimulation and Treadmill Walking
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Acute Effects of Transcutaneous Spinal Stimulation on Spasticity and Gait in Cerebral Palsy
- Plain-language title
- Spinal stimulation during walking for spasticity in cerebral palsyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT07826494, who can take part
- Record updated
- 17 September 2026